A MEDICAL technology firm has been given a multi-million-pound grant to carry out cutting-edge research in Scotland.
EnMovi will use a new £8 million research and development (R&D) base at Strathclyde University in Glasgow to work on its products, including wearable sensors, data analytics and mobile apps designed to help improve patient recovery.
Scottish Enterprise has given a £2.5m R&D grant to the company, which is a newly formed subsidiary of US firm OrthoSensor and McLaren Applied – a technological offshoot of the McLaren Group which includes Formula 1 cars. The new base at the university’s Inovo building is expected to create 19 jobs.
READ MORE: Kirsty Strickland: Women, make 10 mins for a cervical cancer test
Products to be further developed include a mobile app for patients offering tailored rehabilitation guides from their orthopaedic surgeon, enabling them to stay in contact and encourage recovery via a daily pain journal and home exercise plans.
Surgeons can also administer patient surveys via the app and use it with a cloud-based data platform which pairs with a sensor used during knee replacement operations to enable correlation of operative decisions with results and recovery.
Trade, investment and innovation minister Ivan McKee said: “This funding will support EnMovi to capture data and develop wearable technology.
“This will allow for less invasive surgery and faster recovery times for patients.
“This project, which will see a new research and development centre established at the University of Strathclyde’s Inovo building, also brings exciting employment opportunities and will help establish Scotland at the forefront of research into this cutting-edge new technology.”
READ MORE: Brexit: Scottish Government frozen out of Westminster talks
Roman Bensen, EnMovi chief executive, said: “The support provided by Scottish Enterprise and our long-standing collaboration with the prestigious University of Strathclyde will enable us to continue the development of our innovative data analytics and wearable platform to improve patient outcomes globally.”
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here